Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant effect on fentanyl pharmacokinetics
NL-OMON21924Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aprepitant and fentanyl in pain, sponsored by Erasmus MC. Primary endpoints: Fentanyl clearance and Fentanyl pharmacokinetics. Started Dec 2013; status: active, not recruiting.
02
Drugs
aprepitantfentanyl
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON21924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21924.